RFM
GSK icon

Royal Fund Management’s GSK GSK Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$1.12M Buy
29,272
+3,502
+14% +$134K 0.11% 166
2025
Q1
$999K Buy
25,770
+1,745
+7% +$67.6K 0.11% 176
2024
Q4
$813K Sell
24,025
-18,431
-43% -$624K 0.08% 172
2024
Q3
$1.74M Buy
42,456
+19,758
+87% +$808K 0.1% 153
2024
Q2
$875K Sell
22,698
-2,133
-9% -$82.2K 0.07% 175
2024
Q1
$1.06M Buy
24,831
+442
+2% +$18.9K 0.1% 171
2023
Q4
$904K Buy
24,389
+1,065
+5% +$39.5K 0.1% 173
2023
Q3
$846K Buy
23,324
+1,104
+5% +$40K 0.11% 162
2023
Q2
$792K Sell
22,220
-1,589
-7% -$56.6K 0.1% 161
2023
Q1
$847K Buy
23,809
+3,338
+16% +$119K 0.12% 153
2022
Q4
$719K Buy
20,471
+2,201
+12% +$77.3K 0.11% 145
2022
Q3
$537K Buy
18,270
+3,146
+21% +$92.5K 0.1% 140
2022
Q2
$658K Buy
15,124
+6,186
+69% +$269K 0.11% 131
2022
Q1
$389K Buy
8,938
+1,547
+21% +$67.3K 0.06% 156
2021
Q4
$325K Buy
7,391
+998
+16% +$43.9K 0.05% 156
2021
Q3
$244K Buy
6,393
+698
+12% +$26.6K 0.04% 167
2021
Q2
$226K Buy
+5,695
New +$226K 0.04% 177
2020
Q4
Sell
-5,382
Closed -$202K 182
2020
Q3
$202K Sell
5,382
-70
-1% -$2.63K 0.05% 161
2020
Q2
$222K Sell
5,452
-2,477
-31% -$101K 0.08% 135
2020
Q1
$300K Buy
7,929
+857
+12% +$32.4K 0.12% 104
2019
Q4
$332K Buy
7,072
+1,011
+17% +$47.5K 0.08% 110
2019
Q3
$258K Buy
6,061
+92
+2% +$3.92K 0.07% 114
2019
Q2
$238K Sell
5,969
-238
-4% -$9.49K 0.07% 116
2019
Q1
$259K Buy
6,207
+714
+13% +$29.8K 0.08% 110
2018
Q4
$209K Buy
5,493
+184
+3% +$7K 0.08% 105
2018
Q3
$213K Buy
5,309
+1,125
+27% +$45.1K 0.07% 113
2018
Q2
$168K Sell
4,184
-2,083
-33% -$83.6K 0.06% 121
2018
Q1
$244K Sell
6,267
-63
-1% -$2.45K 0.09% 106
2017
Q4
$224K Sell
6,330
-95,910
-94% -$3.39M 0.08% 106
2017
Q3
$4.15M Sell
102,240
-21,934
-18% -$890K 1.65% 24
2017
Q2
$5.35M Sell
124,174
-7,563
-6% -$326K 2.27% 19
2017
Q1
$5.55M Buy
131,737
+10,121
+8% +$427K 2.68% 18
2016
Q4
$4.68M Buy
+121,616
New +$4.68M 2.6% 16